Leitlinie „Diagnostik und Therapie des Morbus Crohn“ – Kurzfassung für Internisten und Hausärzte

[1]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[2]  A. Schreyer,et al.  Diagnostik und Therapie des Morbus Crohn: Ergebnisse einer Evidenz-basierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz Chronisch entzündliche Darmerkrankungen , 2008 .

[3]  A. Schreyer,et al.  S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn” , 2008, Zeitschrift fur Gastroenterologie.

[4]  M. Vatn,et al.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  William J. Tremaine,et al.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.

[6]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[7]  J. Kutner,et al.  Exploring the generalist-subspecialist interface in internal medicine. , 2006, The American journal of medicine.

[8]  Amy K Hara,et al.  A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease , 2006, The American Journal of Gastroenterology.

[9]  B F Warren,et al.  European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis , 2006, Gut.

[10]  A. Otley,et al.  Budesonide for induction of remission in Crohn's disease. , 2005, The Cochrane database of systematic reviews.

[11]  B. Feagan,et al.  Methotrexate for induction of remission in refractory Crohn's disease. , 2005, The Cochrane database of systematic reviews.

[12]  S. Hanauer,et al.  Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  B. Bokemeyer.  Kosten der allgemeinmedizinischen Versorgung von Patienten mit chronisch-entzündlichen Darmerkrankungen , 2003 .

[14]  J. Schölmerich,et al.  Diagnostik und Therapie des M. Crohn , 2003 .

[15]  M. Zeitz,et al.  [Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases]. , 2003, Zeitschrift fur Gastroenterologie.

[16]  H. König,et al.  Kostenerfassung bei chronisch-entzündlichen Darmerkrankungen durch direkte Patientenbefragung mit einem Kostenwochenbuch , 2002 .

[17]  A. Rieber,et al.  Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison , 2002, European Radiology.

[18]  G. Fick,et al.  Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.

[19]  R. Modigliani,et al.  Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. , 2000, The Cochrane database of systematic reviews.